-
Impact of Maternal Vaccination Strategy on RSV-Related Hospital Burden Among Infants Aged Less Than One Year in France: A Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
The Value of Rare Pediatric Disease Designation Program for Decision Making by Drug Developers
Sep 9, 2025, 16:22 PM -
Cognitive Debrief of the PROMIS Parent Proxy Mobility Item Bank in Caregivers of Children Living With Duchenne Muscular Dystrophy
Sep 9, 2025, 16:22 PM -
Predicting Italian EQ-5D-3L Health State Utilities From UK Values: Validation of a Nonlinear Utility Adjustment Model Using Real-World Evidence
Sep 9, 2025, 16:22 PM -
Role of Technical Engagement in NICE Process Under Proportionate Approach to Technology Appraisals
Sep 9, 2025, 16:22 PM -
Exploring LLMs in the Conceptual and Functional Construction of Health Economic Models: A Case Study on Alzheimer's Diagnostic Cost-Effectiveness Model
Sep 9, 2025, 16:22 PM -
Evidence-Driven Simulated Agents to Train Reinforcement Learning for Personalization in mHealth Interventions
Sep 9, 2025, 16:22 PM -
Effectiveness of HPV Vaccination Across Europe: A Comparative Analysis
Sep 9, 2025, 16:22 PM -
Demonstrating the Importance of Modeling Rapid Cancer Progression in Screening Evaluations
Sep 9, 2025, 16:22 PM -
A Comprehensive Assessment of Clinical Studies on Artificial Intelligence-Enabled Interventions: Uncovering Trends and Potential Implications
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of GAAD Algorithm for Hepatocellular Carcinoma Surveillance of Cirrhotic Patients Using Italian Real-World Data
Sep 9, 2025, 16:22 PM -
Treatment Discontinuation in Idiopathic Pulmonary Fibrosis: A Systematic Review of Antifibrotic Drug Use and Tolerability
Sep 9, 2025, 16:22 PM -
Public Health Impact of Herpes Zoster Vaccination in Immunocompromised Adults Aged 18-49 Years in the United Kingdom
Sep 9, 2025, 16:22 PM -
AI in Pragmatic Literature Reviews: A Scoping Review of Current Guidance and Development of a Framework for Integration
Sep 9, 2025, 16:22 PM -
The Impact of Using England Real-World Evidence to Establish the NICE Severity Modifier in Metastatic Urothelial Carcinoma (MUC)
Sep 9, 2025, 16:22 PM -
Stakeholder Involvement in the Health Technology Assessment Process in Ukraine
Sep 9, 2025, 16:22 PM -
Indirect Comparison of Tarlatamab vs. Chemotherapy (CTx) in Patients With Previously Treated, Platinum-Refractory, or Resistant Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Sep 9, 2025, 16:22 PM -
Generating Data for Diversity Planning in Breast Cancer: A Multi-Database Validation Study Using US Claims and HER, Population Census, and Cancer Registry Data in the United States
Sep 9, 2025, 16:22 PM -
Is Europe and European Evidence Development an Afterthought in Pharmaceutical Early Stage Development Decisions? An Exploratory Qualitative Survey
Sep 9, 2025, 16:22 PM -
Recent Changes in HTA and Reimbursement Requirements: Learnings for Global Dossiers
Sep 9, 2025, 16:22 PM
